Crusarthrosis (Ankle Osteoarthritis)
Crusarthrosis is defined as the degeneration of the articular cartilage of the ankle joint. As a rule, this involves cartilage destruction and the formation of osteophytes or spurs, which are abnormal bony growths.
In cases of crusarthrosis, physical exertion on the ankle joint induces pain, erythema, a subcutaneous burning sensation, and potential edema. Joint mobility becomes restricted. Following prolonged rest, the painful sensations subside.
In cases of crusarthrosis, physical exertion on the ankle joint induces pain, erythema, a subcutaneous burning sensation, and potential edema. Joint mobility becomes restricted. Following prolonged rest, the painful sensations subside.
The development of crusarthrosis is frequently preceded by joint trauma or pathology. Even timely intervention and proper rehabilitation do not guarantee the prevention of future ankle osteoarthritis. Regrettably, pathogenesis may initiate within a few months or several decades later, necessitating subsequent treatment of the ankle joint.
Risk Groups
The high-risk group includes runners, track and field athletes, pregnant women, and individuals with obesity.
Arthro-medullary shunting is a patented Russian technique that has been successfully utilized since 2010 for the treatment of ankle joint pathologies.
The method integrates advanced medical technologies with the utilization of the body's autologous resources.
Indications for Arthro-Medullary Shunting of the Ankle Joint
- Stage I–III crusarthrosis
- Anterior and posterior ankle impingement syndrome
- Avascular necrosis (aseptic necrosis) of the talus
- Chronic pain syndrome (lasting more than 6 months)
- The waiting period for joint arthroplasty (replacement)
- High body mass index (BMI) acting as a contraindication for joint replacement
- Inability or unwillingness to undergo arthroplasty
